Novelion Therapeutics Inc (NASDAQ:NVLN)

4.05
BATS BZX Real-Time Price
As of 10:39am ET
 -0.10 / -2.41%
Today’s Change
3.08
Today|||52-Week Range
10.68
+29.81%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Novelion Therapeutics Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +72.84% increase from the last price of 4.05.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Novelion Therapeutics Inc. This rating has held steady since May, when it was downgraded from a Outperform rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$37.2M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 62.50%
 
 
 
 
 
 
Growthannually 0.31%
 
 
 
 
 
 

Sales

Growthquarterly 35.35%
 
 
 
 
 
 
Growthannually 0.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.